Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study

Background Stroke is among the leading causes of morbidity and mortality worldwide. Without reliable prediction models and outcome measurements, comparison of care systems is impossible. We analyzed prospectively collected data from 4 countries to explore the importance of stroke severity in outcome prediction. Methods and Results For 2 months, all acute ischemic stroke patients from the hospitals participating in the Global Comparators Stroke GOAL (Global Outcomes Accelerated Learning) collaboration received a National Institutes of Health Stroke Scale (NIHSS) score on admission and a modified Rankin Scale score at 30 and 90 days. These data were added to the administrative data set, and risk prediction models including age, sex, comorbidity index, and NIHSS were derived for in‐hospital death within 7 days, all in‐hospital death, and death and good outcome at 30 and 90 days. The relative importance of each variable was assessed using the proportion of explained variation. Of 1034 admissions for acute ischemic stroke, 614 had a full set of NIHSS and both modified Rankin Scale values recorded; of these, 507 patients could be linked to administrative data. The marginal proportion of explained variation was 0.7% to 4.0% for comorbidity index, and 11.3 to 25.0 for NIHSS score. The percentage explained by the model varied by outcome (16.6–29.1%) and was highest for good outcome at 30 and 90 days. There was high agreement between 30‐ and 90‐day modified Rankin Scale scores (weighted κ=0.82). Conclusions In this prospective pilot study, the baseline NIHSS score was essential for prediction of acute ischemic stroke outcomes, followed by age; whereas traditional comorbidity index contributed little to the overall model. Future studies of stroke outcomes between different care systems will benefit from including a baseline NIHSS score.

[1]  C. Wolfe,et al.  Derivation and External Validation of a Case Mix Model for the Standardized Reporting of 30-Day Stroke Mortality Rates , 2014, Stroke.

[2]  P. Deyn,et al.  Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke , 2014, Clinical Neurology and Neurosurgery.

[3]  J. Broderick,et al.  Stroke Outcomes Measures Must Be Appropriately Risk Adjusted to Ensure Quality Care of Patients: A Presidential Advisory From the American Heart Association/American Stroke Association , 2014, Stroke.

[4]  R. Rosenfeld Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[5]  A. Bottle,et al.  Global comparators project: international comparison of hospital outcomes using administrative data. , 2013, Health services research.

[6]  Tzu-Ching Wu,et al.  Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke , 2013, Stroke.

[7]  V. Durkalski,et al.  The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes , 2013, Trials.

[8]  David S Liebeskind,et al.  Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial , 2013, Journal of NeuroInterventional Surgery.

[9]  Adrian F Hernandez,et al.  Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. , 2012, JAMA.

[10]  Jeffrey L. Saver,et al.  Relationship Between Neurologic Deficit Severity and Final Functional Outcome Shifts and Strengthens During First Hours After Onset , 2012, Stroke.

[11]  Eric E. Smith,et al.  Predictors of Increased Intravenous Tissue Plasminogen Activator Use Among Hospitals Participating in the Massachusetts Primary Stroke Service Program , 2012, Circulation. Cardiovascular quality and outcomes.

[12]  Eric E. Smith,et al.  Are Quality Improvements in the Get With The Guidelines-Stroke Program Related to Better Care or Better Data Documentation? , 2011, Circulation. Cardiovascular quality and outcomes.

[13]  J. Switzer,et al.  Simplified Modified Rankin Scale Questionnaire: Reproducibility Over the Telephone and Validation With Quality of Life , 2011, Stroke.

[14]  J. Saver,et al.  Disability status at 1 month is a reliable proxy for final ischemic stroke outcome , 2010, Neurology.

[15]  Askiel Bruno,et al.  Improving Modified Rankin Scale Assessment With a Simplified Questionnaire , 2010, Stroke.

[16]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[17]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[18]  Eric E. Smith,et al.  Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010, Circulation. Cardiovascular quality and outcomes.

[19]  P. M. Janssen,et al.  Comparison of Telephone and Face-to-Face Assessment of the Modified Rankin Scale , 2009, Cerebrovascular Diseases.

[20]  J. Saver,et al.  Day-90 Acute Ischemic Stroke Outcomes Can Be Derived from Early Functional Activity Level , 2009, Cerebrovascular Diseases.

[21]  M. Walters,et al.  Reliability of the Modified Rankin Scale: A Systematic Review , 2009, Stroke.

[22]  V. Feigin,et al.  Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review , 2009, The Lancet Neurology.

[23]  Ralph L. Sacco,et al.  Stroke Outcome in Clinical Trial Patients Deriving From Different Countries , 2009, Stroke.

[24]  Christian Weimar,et al.  Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials , 2008, Stroke.

[25]  S. Downie,et al.  Ictal eye closure is a reliable indicator for psychogenic nonepileptic seizures , 2006, Neurology.

[26]  Jamie L Banks,et al.  Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis , 2007, Stroke.

[27]  J. Saver,et al.  Confirmation of tPA Treatment Effect by Baseline Severity-Adjusted End Point Reanalysis of the NINDS-tPA Stroke Trials , 2007, Stroke.

[28]  R. Sacco,et al.  Quality improvement in acute stroke , 2006, Neurology.

[29]  Jan Potter,et al.  Reliability of the Modified Rankin Scale Across Multiple Raters: Benefits of a Structured Interview , 2005, Stroke.

[30]  J. Swieten Interobserver Agreement for the Assessment of Handicap in Stroke Patients , 2005 .

[31]  Georg Heinze,et al.  Comparing the importance of prognostic factors in Cox and logistic regression using SAS , 2003, Comput. Methods Programs Biomed..

[32]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[33]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[34]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[35]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[36]  Jacob Cohen,et al.  Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .

[37]  J. Rankin Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis , 1957, Scottish medical journal.